Stock screenerAll disclosures →
EDGAR →
AVTX
Conviction 96HealthcareScan · Thu, Jun 25, 2026AVTX$18.00-0.88%
ResistanceSupportVol 14Insider sell16
Vol MA14 2.29M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price18.00
Change-0.88%
Gap-0.06%
Rel volume5.09×
Avg volume2.06M
Avg $ vol32M
SMA 2014.98
SMA 5015.76
SMA 20015.70
Price vs 50+14.22%
Price vs 200+14.66%
MA stackbullish
50/200 crossgolden · 1d
Supertrendup · 14.72
RSI (14)64
MACD hist0.55
MACD crossbull · 6d
Stoch %K / %D89 / 90
ADX (14)22
+DI / −DI32 / 15
RSI divergence—
MACD divergence—
ATR %+6.75%
ADR %7.13%
52w high22.87
52w low4.75
From 52w high-21.29%
Above 52w low+278.95%
New 52w highNo
SqueezeOff
Bollinger width45.52%
%B0.94
Donchian pos89.11%
Donchian high18.67
Donchian low12.52
AVWAP (52w high)17.06
vs AVWAP high+5.54%
AVWAP (52w low)16.23
vs AVWAP low+10.91%
OBV trendDown
Chaikin MF (20)-0.31
Today vs 20d5.09×
Avg vol (14d)2.29M
Avg vol (20d)2.06M
Avg $ vol (20d)32M
Market cap946.18M
RS 3m (vs SPY)+22.76%
RS 6m (vs SPY)-10.10%
RS line new highNo
Trend template7/8
Technical rank69.3
1 week+16.88%
1 month+12.36%
3 months+29.03%
6 months-6.10%
1 year+263.64%
YTD+5.76%
P/E-12.09
P/B13.85
P/S—
P/FCF-18.35
EPS-5.84
Div yield—
ROE-114.55%
ROA-78.35%
Debt/Eq0.22
Current7.66
EV/EBITDA-12.90
Gross margin—
Net margin—
Rev growth-86.62%
EPS growth-122.78%
Price target45.90
Target upside155.00%
Analyst ratingBuy
Institutional61.75%
Ent. value936.5M
Revenue0
Net income-19.63M
Gross profit—
Free cash flow-51.55M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out52.57M
Employees33
ListedFri, Nov 13, 2015
Free float21.22M
Float %86.6%
Short interest6.38M
Days to cover4.4d
Short volume69.3%
Squeeze score96 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.66 · 6 est
Last EPS vs est−$0.98 vs −$1.00
Last surprise+2.0% beat
Setup gradeA+
Conviction96 / 100
Pattern quality—
Tech rank69.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.34
Support13.90
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AVTX
No recent disclosed trades by Congress in AVTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AVTX · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-23 | Sell | 1.45K | $26K | 2026-06-23 | 2026-06-25 |
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-23 | Exercise | 1.45K | $12K | 2026-06-23 | 2026-06-25 |
Doyle Mittie Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-23 | Exercise | 1.45K | — | 2026-06-23 | 2026-06-25 |
Philip Ron M Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 40.2K | — | 2026-06-23 | 2026-06-25 |
VARKI PAUL Chief Legal Officer · Common Stock · 2026-06-10 | Tax | 1.08K | $14K | 2026-06-10 | 2026-06-12 |
Sullivan Christopher Ryan Chief Financial Officer · Common Stock · 2026-06-10 | Tax | 138 | $2K | 2026-06-10 | 2026-06-12 |
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-10 | Tax | 1.08K | $14K | 2026-06-10 | 2026-06-12 |
Riley Jennifer Chief Strategy Officer · Common Stock · 2026-06-10 | Tax | 588 | $8K | 2026-06-10 | 2026-06-12 |
Jain Rita Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 20.1K | $0 | 2026-06-02 | 2026-06-04 |
KANTOFF AARON Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 20.1K | $0 | 2026-06-02 | 2026-06-04 |
SEC filings
EDGAR filings in AVTX · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.